Xuefeng Xia

3.4k total citations · 2 hit papers
92 papers, 1.3k citations indexed

About

Xuefeng Xia is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Xuefeng Xia has authored 92 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Cancer Research, 52 papers in Pulmonary and Respiratory Medicine and 43 papers in Oncology. Recurrent topics in Xuefeng Xia's work include Cancer Genomics and Diagnostics (51 papers), Lung Cancer Treatments and Mutations (37 papers) and Genetic factors in colorectal cancer (13 papers). Xuefeng Xia is often cited by papers focused on Cancer Genomics and Diagnostics (51 papers), Lung Cancer Treatments and Mutations (37 papers) and Genetic factors in colorectal cancer (13 papers). Xuefeng Xia collaborates with scholars based in China, United States and Ethiopia. Xuefeng Xia's co-authors include Yanfang Guan, Xin Yi, Lianpeng Chang, Ling Yang, Rongrong Chen, Xin Yi, Yaping Xu, Ling Yang, P. Andrew Futreal and Huaibo Sun and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Xuefeng Xia

82 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer

2018 307 citations Yanfang Guan, Xuefeng Xia et al. Nature Communications profile →
Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients

2021 201 citations Yongliang Zhang, Yu Yao et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xuefeng Xia China	17	721	608	564	450	205	92	1.3k
Lianpeng Chang China	18	520 0.7×	723 1.2×	556 1.0×	275 0.6×	241 1.2×	40	1.3k
Vicki L. Keedy United States	20	321 0.4×	806 1.3×	766 1.4×	518 1.2×	157 0.8×	77	1.5k
Marina Baretti United States	13	333 0.5×	531 0.9×	293 0.5×	367 0.8×	211 1.0×	50	969
Stephen P. Anthony United States	14	603 0.8×	881 1.4×	368 0.7×	482 1.1×	199 1.0×	53	1.5k
А. Н. Махсон Russia	15	397 0.6×	1.2k 2.0×	563 1.0×	310 0.7×	112 0.5×	23	1.7k
Gayle Jameson United States	19	556 0.8×	944 1.6×	399 0.7×	546 1.2×	131 0.6×	76	1.6k
Zachary R. Chalmers United States	15	349 0.5×	584 1.0×	580 1.0×	649 1.4×	129 0.6×	35	1.4k
Han Han‐Zhang China	22	409 0.6×	672 1.1×	710 1.3×	389 0.9×	240 1.2×	57	1.1k
Petros Nikolinakos United States	20	869 1.2×	1.5k 2.4×	986 1.7×	628 1.4×	338 1.6×	51	2.4k
Dora Hatzidaki Greece	22	373 0.5×	1.1k 1.9×	819 1.5×	390 0.9×	79 0.4×	67	1.5k

Countries citing papers authored by Xuefeng Xia

Since Specialization

Citations

This map shows the geographic impact of Xuefeng Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuefeng Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuefeng Xia more than expected).

Fields of papers citing papers by Xuefeng Xia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuefeng Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuefeng Xia. The network helps show where Xuefeng Xia may publish in the future.

Co-authorship network of co-authors of Xuefeng Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Xuefeng Xia. A scholar is included among the top collaborators of Xuefeng Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuefeng Xia. Xuefeng Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhan, Qing, Menɡ Ninɡ, Hongjie Guo, et al.. (2024). Depletion‐assisted multiplexed cell‐free RNA sequencing reveals distinct human and microbial signatures in plasma versus extracellular vesicles. Clinical and Translational Medicine. 14(7). e1760–e1760. 5 indexed citations

Wang, Xingzhou, Heng Yu, Xuefeng Xia, et al.. (2024). Infiltrating characteristics and prognostic value of tertiary lymphoid structures in resected gastric neuroendocrine neoplasm patients. Clinical & Translational Immunology. 13(2). e1489–e1489. 1 indexed citations

Huang, Jin, Guofeng Zhao, Peng Qiu, et al.. (2023). Analysis of genomic and immune intratumor heterogeneity in linitis plastica via multiregional exome and T‐cell receptor sequencing. Molecular Oncology. 17(8). 1531–1544. 2 indexed citations

Zhu, Chuandong, Yufeng Xie, Qiang Li, et al.. (2023). CPSF6-mediated XBP1 3’UTR shortening attenuates cisplatin-induced ER stress and elevates chemo-resistance in lung adenocarcinoma. Drug Resistance Updates. 68. 100933–100933. 45 indexed citations

Wang, Jianchao, Liyan Lin, Xuan Gao, et al.. (2023). Collagen-related gene expression level predicts the prognosis and immune therapy response. Gastric Cancer. 26(6). 891–903. 7 indexed citations

Wu, Guiying, Tianyu Cui, Liyan Ji, et al.. (2023). DELFMUT: duplex sequencing-oriented depth estimation model for stable detection of low-frequency mutations. Briefings in Bioinformatics. 24(5). 1 indexed citations

Zhang, Li, Jian‐Yong Ding, Xuefeng Xia, et al.. (2023). P1.21-05 The Upregulated Expression of IGF2BP2 Predicts Poor Prognosis in Lung Adenocarcinoma and Affects Immune Microenvironment and Drug Sensitivity. Journal of Thoracic Oncology. 18(11). S235–S236. 1 indexed citations

Zhang, Jia‐Tao, Song Dong, Jiaying Zhou, et al.. (2022). Intratumoral genetic and immune microenvironmental heterogeneity in T4N0M0 (diameter ≥ 7 cm) non‐small cell lung cancers. Thoracic Cancer. 13(9). 1333–1341. 2 indexed citations

Wu, Xiaonan, Jun Zhao, Ling Yang, et al.. (2022). Next-generation Sequencing Reveals Age-dependent Genetic Underpinnings in Lung adenocarcinoma. Journal of Cancer. 13(5). 1565–1572. 9 indexed citations

10.

Hu, Zhe-Yu, Yu Tang, Liping Liu, et al.. (2022). Subtyping of metastatic breast cancer based on plasma circulating tumor DNA alterations: An observational, multicentre platform study. EClinicalMedicine. 51. 101567–101567. 6 indexed citations

11.

Yang, Xiaodan, Jia Zhong, Minglei Zhuo, et al.. (2021). Genetic and treatment profiles of patients with concurrent Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) mutations. BMC Cancer. 21(1). 1107–1107. 4 indexed citations

12.

Zhang, Yongliang, Yu Yao, Yaping Xu, et al.. (2021). Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients. Nature Communications. 12(1). 11–11. 201 indexed citations breakdown →

13.

Zhao, Jun, Gen Lin, Minglei Zhuo, et al.. (2019). Next-generation sequencing based mutation profiling reveals heterogeneity of clinical response and resistance to osimertinib. Lung Cancer. 141. 114–118. 30 indexed citations

14.

Wang, Yan, Chuanhua Zhao, Lianpeng Chang, et al.. (2019). Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer. EBioMedicine. 43. 261–269. 62 indexed citations

15.

Ma, Fei, Yanfang Guan, Zongbi Yi, et al.. (2019). Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer. International Journal of Cancer. 146(5). 1359–1368. 63 indexed citations

16.

Liu, Jingyu, Jing Li, Hui Wang, et al.. (2019). Clinical and genetic risk factors for Fulvestrant treatment in post-menopause ER-positive advanced breast cancer patients. Journal of Translational Medicine. 17(1). 27–27. 18 indexed citations

17.

Wang, Lin, et al.. (2019). P2.04-54 Characteristic of MSI-H Lung Cancer Patients Identified with Targeted Next-Generation Sequencing. Journal of Thoracic Oncology. 14(10). S729–S729. 4 indexed citations

18.

Jia, Wang, et al.. (2019). P2.14-38 ATAD2B-ALK, a Novel Fusion in Lung Adenocarcinoma Identified Using Next-Generation Sequencing (NGS). Journal of Thoracic Oncology. 14(10). S844–S844. 1 indexed citations

19.

Tang, Chad, Alexandre Reuben, Lianpeng Chang, et al.. (2019). Immune and Circulating Tumor DNA Profiling After Radiation Treatment for Oligometastatic Non-Small Cell Lung Cancer: Translational Correlatives from a Mature Randomized Phase II Trial. International Journal of Radiation Oncology*Biology*Physics. 106(2). 349–357. 30 indexed citations

20.

Zhou, Jiaolin, Lianpeng Chang, Yanfang Guan, et al.. (2016). Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal Cancer. PLoS ONE. 11(7). e0159708–e0159708. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact